Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review

Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Faes Farma SA (Faes Farma) develops, manufactures, and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over the counter (OTC) medications, baby foods, skin-care treatment products. It exports raw materials and finished pharmaceutical products to pharmaceutical companies worldwide. Faes Farma also owns animal nutrition and healthcare company such as Ingaso farm. The company operates manufacturing and R&D center in Leioa, Spain, laboratory, production plants, subsidiaries, and commercial offices in international markets. The company markets the products in Latin America, Asia, Europe, Africa, and the Middle East. Faes Farma is headquartered in Leioa, Spain.

Faes Farma SA Key Recent Developments

May 02,2024: Faes Farma Proposes to Appoint Eduardo Recoder de la Cuadra as its New CEO
Apr 26,2024: Faes Farma Increases its Net Profit by 10% in the First Quarter, up to 30.4 Million Euros
Feb 20,2024: Faes Farma Reaches a Record Net Profit of 92 Million Euros, 2.5% More Than in 2022
Feb 20,2024: We Present Our New Website. A Renewed Portal for an Era of Health and Sustainability

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Faes Farma SA - Key Facts
Faes Farma SA - Key Employees
Faes Farma SA - Major Products and Services
Faes Farma SA - History
Faes Farma SA - Company Statement
Faes Farma SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Faes Farma SA - Business Description
Business Segment: Animal Nutrition and Health
Overview
Performance
Business Segment: Pharmaceutical and Healthcare Specialties
Overview
Performance
Business Segment: Pharmaceutical Raw Materials
Overview
Performance
R&D Overview
Faes Farma SA - Corporate Strategy
Faes Farma SA - SWOT Analysis
SWOT Analysis - Overview
Faes Farma SA - Strengths
Faes Farma SA - Weaknesses
Faes Farma SA - Opportunities
Faes Farma SA - Threats
Faes Farma SA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Faes Farma SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 02, 2024: Faes Farma Proposes to Appoint Eduardo Recoder de la Cuadra as its New CEO
Apr 26, 2024: Faes Farma Increases its Net Profit by 10% in the First Quarter, up to 30.4 Million Euros
Feb 20, 2024: Faes Farma Reaches a Record Net Profit of 92 Million Euros, 2.5% More Than in 2022
Feb 20, 2024: We Present Our New Website. A Renewed Portal for an Era of Health and Sustainability
Oct 25, 2023: Faes Farma Reaches a Net Profit of 74 Million Euros in the First Nine Months of 2023
Jul 28, 2023: Faes Farma Achieves a Net Profit of 53 Million Euros in the First Half of the Year
Apr 26, 2023: Faes Farma Increases Its Net Profit by 4% in the First Quarter, Reaching 27.6 Million Euros
Apr 19, 2023: Faes Farma : HANTURA Project
Mar 14, 2023: Development of new diagnostic devices and immunomodulatory drugs based on 25(OH)D and VDR receptor agonists for the treatment of vitamin D deficiency and associated pathologies
Feb 28, 2023: Faes Farma achieves a consolidated profit of 89.5 million euros, 8.6% more than in 2021
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Faes Farma SA, Key Facts
Faes Farma SA, Key Employees
Faes Farma SA, Major Products and Services
Faes Farma SA, History
Faes Farma SA, Subsidiaries
Faes Farma SA, Key Competitors
Faes Farma SA, Ratios based on current share price
Faes Farma SA, Annual Ratios
Faes Farma SA, Annual Ratios (Cont...1)
Faes Farma SA, Annual Ratios (Cont...2)
Faes Farma SA, Interim Ratios
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Faes Farma SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Faes Farma SA, Performance Chart (2019 - 2023)
Faes Farma SA, Ratio Charts
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings